Acute Mesenteric Ischemia - Arterial Revascularization

Key Points

• CTA should be obtained immediately when acute mesenteric ischemia is suspected; normal lactate does not rule it out.
• Embolic SMA occlusion and in-situ atherosclerotic thrombosis have different anatomic patterns and long-term treatment needs.
• Start IV unfractionated heparin unless contraindicated.
• Broad-spectrum antibiotics are appropriate because ischemic bowel loses mucosal barrier integrity.
• Peritonitis or perforation requires urgent laparotomy and bowel viability assessment.
• Endovascular revascularization is increasingly favored when there is no peritonitis and expertise is available.
• Restore blood flow before declaring borderline bowel nonviable whenever possible.
• Planned second-look surgery can prevent both missed necrosis and unnecessary massive bowel resection.

Algorithm

1. Recognize sudden severe abdominal pain and vascular risk factors; obtain immediate surgical and vascular consultation.
2. Order CTA abdomen and pelvis without waiting for lactate normalization or renal optimization.
3. Start IV heparin, broad-spectrum antibiotics, analgesia, and hemodynamic resuscitation unless contraindicated.
4. Assess for peritonitis, perforation, shock, and imaging signs of advanced bowel necrosis.
5. If peritonitis is present, proceed to operative exploration with revascularization and bowel assessment.
6. If no peritonitis, consider rapid endovascular revascularization based on embolic or thrombotic anatomy.
7. Reassess bowel viability after reperfusion and use second-look laparotomy when uncertainty remains.
8. Define embolic source or atherosclerotic disease and establish long-term antithrombotic and vascular prevention.

Clinical Synopsis & Reasoning

Arterial mesenteric ischemia classically causes severe abdominal pain that may initially appear disproportionate to examination findings. This pattern is neither universal nor sufficiently sensitive to delay imaging when suspicion is high. Embolic occlusion often occurs abruptly in patients with atrial fibrillation, recent myocardial infarction, or another embolic source and commonly lodges distal to the SMA origin. In-situ thrombosis often arises on chronic atherosclerotic mesenteric disease and may involve the vessel origin, with a preceding history of postprandial pain, food avoidance, weight loss, or diffuse vascular disease.

CTA of the abdomen and pelvis with arterial evaluation is the diagnostic study of choice and should be obtained without delay. Concern about contrast-associated kidney injury should not outweigh the mortality risk of missed bowel ischemia. Findings include arterial filling defects, vessel cutoff, bowel-wall hypoenhancement, pneumatosis, portal venous gas, mesenteric edema, or free fluid. Lactate can be elevated but is neither sensitive nor early enough to exclude disease. Leukocytosis and metabolic acidosis are nonspecific. A normal lactate in a patient with convincing symptoms should not delay CTA.

The examination must determine whether peritonitis is present. Guarding, rebound, rigidity, perforation, or clear necrotic bowel shifts management toward immediate laparotomy because bowel viability and source control are required. In patients without peritonitis, endovascular revascularization may restore flow with less physiologic insult. The team should identify embolic versus thrombotic pattern, assess celiac and inferior mesenteric circulation, and evaluate for aortic disease because these features shape the revascularization plan.

Treatment Strategy & Disposition

Begin resuscitation with oxygen as needed, IV access, judicious crystalloid, blood products if indicated, correction of major electrolyte and acid-base abnormalities, and broad-spectrum antibiotics covering enteric gram-negative and anaerobic organisms because mucosal barrier failure can cause bacterial translocation. Start systemic unfractionated heparin promptly unless active bleeding or another strong contraindication exists. Avoid excessive vasoconstriction when possible, although vasopressors may be necessary to support life-threatening shock. Norepinephrine is generally preferred when a vasopressor is required.

Revascularization should not wait for prolonged medical stabilization. For embolic occlusion with threatened bowel, options include open embolectomy, endovascular aspiration or thrombectomy, catheter-directed techniques, or hybrid approaches. Thrombotic ostial disease may require angioplasty and stenting, bypass, or hybrid revascularization. Endovascular-first treatment is increasingly used in patients without peritonitis when expertise is available. Open surgery is essential when bowel viability must be directly assessed, peritonitis is present, or endovascular treatment is not feasible.

At laparotomy, clearly necrotic bowel is resected while borderline segments may be reassessed after restoring flow. Damage-control surgery and a planned second-look operation 24 to 48 hours later are common when viability is uncertain. Massive resection can cause short-bowel syndrome, so preserving viable intestine is important. Postoperative care includes anticoagulation strategy based on etiology, evaluation for atrial fibrillation or cardiac embolic source, aggressive atherosclerotic risk reduction for thrombotic disease, nutrition planning, and surveillance of the revascularization.

Epidemiology / Risk Factors

• Arterial embolism and thrombosis account for a large fraction of acute mesenteric ischemia.
• Atrial fibrillation is a major risk factor for embolic SMA occlusion.
• Diffuse atherosclerosis, smoking, and chronic mesenteric symptoms support in-situ thrombosis.
• Mortality remains high, especially after bowel necrosis or delayed diagnosis.

Investigations

Etiology Clues

Pharmacology

Prognosis / Complications

• Outcome depends heavily on time to diagnosis and reperfusion.
• Patients treated before transmural bowel necrosis have better survival and bowel preservation.
• Extensive bowel loss can result in short-bowel syndrome, long-term parenteral nutrition, or intestinal failure.
• Recurrent embolism or thrombosis is preventable when the underlying cause is identified and treated.

Patient Education / Counseling

• Severe abdominal pain with relatively mild early examination findings can still represent a surgical emergency.
• Patients with atrial fibrillation should understand the role of long-term anticoagulation when appropriate.
• Patients with atherosclerotic disease need smoking cessation, lipid treatment, blood-pressure control, and antiplatelet therapy as indicated.
• After bowel resection, provide nutrition counseling and specialty support for malabsorption or short-bowel symptoms.
• Seek urgent evaluation for recurrent sudden abdominal pain after prior mesenteric ischemia.

Notes

WSES guidance emphasizes that diagnostic delay is one of the most modifiable causes of death in acute mesenteric ischemia. Lactate, D-dimer, and serial observation should not be used as gatekeepers before CTA when clinical suspicion is meaningful.

Revascularization technique is center- and anatomy-dependent. Endovascular options have expanded rapidly, but open surgery remains indispensable for peritonitis, uncertain bowel viability, or anatomy that cannot be treated catheterically.

References

1. WSES Updated Guidelines for Acute Mesenteric Ischemia — Link